Rose Oil
drugOn this page
Also known as Aniba rosaeodora oilFEMA NO. 2156FEMA NO. 2988ROSA GALLICAFEMA NO. 2993Oil of roseRosa gallica flower waterRose absolute (rosa gallica)unspecifiedRosewood oilbrazilian
Summary
Rose Oil (CHEMBL2108484) is a phase-3 clinical-stage unknown.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Clinical trials: 1
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108484 |
| Name | Rose Oil |
| Type | Unknown |
| Max phase | 3 |
Also known as: Aniba rosaeodora oil, FEMA NO. 2156, FEMA NO. 2988, ROSA GALLICA, FEMA NO. 2993, Oil of rose, Rosa gallica flower water, Rose absolute (rosa gallica), Rose oil, unspecified, Rosewood oil, brazilian
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indications (0 at ChEMBL trial phase 4).
Clinical trials
Total trials: 1.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03377088 | Not specified | SUSPENDED | Aromatherapy Randomization of Pain Management in Adults |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.